Saatvik Green Energy Limited announces a new order win

The Gopalpur facility’s Phase I nameplate capacity is approximately 1.3 GW of solar PV modules, with commercial production commencing on 2 November 2026 ^[1].

Using the company’s 4.8 GW of live pre-commissioning manufacturing capacity as the baseline ^[2]:

• Pre-commissioning capacity: 4.8 GW
• Gopalpur Phase I addition: +1.3 GW
• Post-commissioning aggregate: approximately 6.1 GW
• Increase: 1.3 GW, or approximately 27.1% versus the 4.8 GW baseline

The 6.1 GW figure is a derived module-capacity total and should not be combined with the separately reported cell, encapsulant, or planned ingot-and-wafer capacities, which represent different manufacturing stages. The remaining Gopalpur capacity is planned for commissioning in subsequent phases ^[1].

Yes—but the evidence points to a two-stage capability shift, not yet a proven change in the reported product mix. Gopalpur’s commercial module production began on 2 November 2026 with Phase I capacity of approximately 1.3 GW ^[1]. Separately, the associated 2.4 GW cell facility has applied for ALMM List-II approval for monocrystalline bifacial N-TOPCon cells, indicating a move upstream into higher-efficiency technology ^[3]. The existing mix is not broken out by technology, so the extent to which TOPCon differs from the current module portfolio cannot be quantified.

Gross-margin implication

The current consolidated gross-margin base is:

• Q1 FY27: 21.7% ^[4]
• FY26: 22.2% ^[5]
• TTM Q1 FY27: 20.4% ^[6]
• Q1 FY26: 29.6% ^[7]

Thus, the company is entering the Gopalpur ramp from a relatively softer gross-margin base: Q1 FY27 was 7.9 percentage points below Q1 FY26, calculated from the reported margins ^{[7] [4]}. These figures predate the November 2026 commencement of commercial production and therefore do not yet capture the facility’s operating contribution.

The economic bridge is asymmetric:

• Potential structural benefit: internal cell manufacturing could reduce dependence on externally sourced cells, retain more value within the group, and improve the economics of high-wattage N-TOPCon modules once utilization and yields stabilize. The planned Phase I configuration includes 2.4 GW of cell and 4 GW of module capacity ^[8].
• Near-term pressure: the facility may initially dilute blended gross margin through ramp-up inefficiency, lower utilization, start-up scrap, qualification costs and a higher fixed-cost burden spread over early production. This is an inference from the capacity ramp, not a reported company margin forecast.
• Mix effect: TOPCon could support better realization if customers pay for efficiency and domestic-content eligibility, but the cited sources do not report a TOPCon price premium, yield advantage, cell cost, or product-level gross margin.

Analyst read: Gopalpur creates the possibility of a higher-quality, more integrated margin pool, but the near-term blended gross margin is more likely to be driven by utilization, yield and the share of captive cells consumed than by the technology label alone. On current evidence, the direction is strategically margin-accretive at maturity but not yet quantifiable; a temporary margin drag during commissioning remains plausible. The company has not separately reported Gopalpur’s gross margin, utilization, cell-versus-module cost structure, or the existing portfolio’s technology mix.

Gopalpur-specific capex and its financing split cannot be confirmed from the latest reported figures.

• Total capex: The company reported consolidated FY26 capex of ₹601.41 Cr, but this is total company capex and was not allocated specifically to the Gopalpur facility ^[9].
• Long-term debt: Non-current borrowings stood at ₹210.82 Cr in Q1 FY27 ^[10]. The balance-sheet figure does not identify this borrowing as Gopalpur project finance.
• Internal accruals: The portion of Gopalpur capex funded through internal accruals was not separately disclosed.
• Important: It would not be valid to calculate internal funding as ₹601.41 Cr less ₹210.82 Cr, because the two figures are not project-specific or explicitly linked as capex funding sources.

Accordingly, the latest disclosure supports only company-wide FY26 capex of ₹601.41 Cr and non-current borrowings of ₹210.82 Cr; it does not establish the total Gopalpur investment or the debt-versus-internal-accrual split.